September 8, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance,
100 F Street, N.E.
Washington, D.C. 20549-3628
Attention: Jane Park
| Re: | Apexigen, Inc. |
Registration Statement on Form S-1
File No. 333-266846
Acceleration Request
| Requested Date: |
September 9, 2022 | |
| Requested Time: |
4:05 p.m. Eastern Time, | |
| or as soon thereafter as practicable |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Apexigen, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-l (File No. 333-266846) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.
Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, Professional Corporation, by calling Michael E. Coke at (650) 565-3596.
Please direct any questions or comments regarding this acceleration request to Michael E. Coke at (650) 565-3596.
[Signature Page Follows]
| Sincerely, |
| APEXIGEN, INC. |
| /s/ Xiaodong Yang |
| Xiaodong Yang, M.D., Ph.D. |
| President and Chief Executive Officer |
| cc: | Francis Sarena, Apexigen, Inc. |
Michael E. Coke, Wilson Sonsini Goodrich & Rosati, Professional Corporation
Lance Brady, Wilson Sonsini Goodrich & Rosati, Professional Corporation